Medical Devices · Published Aug 2026
Kidney Stone Extraction Balloon Market
The Kidney Stone Extraction Balloon Market is projected to grow from USD 1.33 billion in 2025 to USD 2.72 billion by 2035, at a compound annual growth rate (CAGR) of 7.4%. This expansion is driven by the rising global prevalence of nephrolithiasis, increasing adoption of minimally invasive urological procedures, and technological advancements in balloon catheter design. Key applications span urology and gastroenterology, with hospitals and ambulatory surgical centers serving as primary end users.
The market is characterized by a competitive landscape dominated by established medical device manufacturers, including Medtronic, Abbott, and Boston Scientific.
Market size
Growth trajectory through 2035
Kidney Stone Extraction Balloon Market · Market size 2025–2035
Base year 2025 · Forecast 2035 · USD Billion
Source: Exactitude Consultancy analyst modeling. Anchor values from primary + secondary research; intermediate years interpolated from the CAGR trajectory. Full annual data pack included with the report.
What's new in this edition
Here's what changed
This edition rebased the forecast to 2025, added tracked developments through the last quarter, and re-cited every numeric claim against live public sources.
Recent developments tracked
-
Development 01 Technological advancements
- Introduction of next-generation balloon catheters with integrated imaging capabilities, such as ultrasound or fluoroscopy, to enhance procedural precision and safety.
-
Development 02 Robotic-assisted integration
- Adoption of balloon extraction devices in robotic-assisted urology surgeries, creating new opportunities for minimally invasive workflows.
-
2025 Regulatory approvals
- Favorable regulatory developments post-2025 have accelerated the approval of innovative balloon-based solutions, supporting market growth.
-
Development 04 Strategic acquisitions
- Key players are acquiring smaller firms to expand their product portfolios and strengthen their market positions.
Emerging opportunities added
- Expansion in emerging markets Rapidly growing healthcare infrastructure in Asia-Pacific and Latin America presents untapped opportunities for market penetration.
- Integration with digital health and AI Adoption of smart balloon technologies with real-time feedback capabilities can enhance procedural accuracy and patient outcomes.
- Development of patient-specific devices Customizable balloon designs tailored to individual anatomy and stone composition can improve clinical efficacy and reduce complications.
- Increased focus on outpatient procedures The shift toward low-risk, outpatient settings post-COVID-19 underscores the need for efficient, disposable extraction devices.
Executive snapshot
The four things that matter
A condensed view of the market at a glance — sized, shaped, and pressure-tested against live public sources.
Market size · 2025–2035
forecast for 2035
- 2025 base
- $1.33 Bn
- CAGR
- 7.40%
- Expansion
- 2.0×
Market shape
top segment · 40.7% share
- Leading region
- North America
- Top end-user
- Hospitals
- Top-5 concentration
- Low to medium · ~42%
Forces at play
▲ top tailwind
- ▼ headwind
- High procedural costs
- Named players
- 15 profiled
- Growth peak
- 2027–2031
Latest development
Technological advancements: Introduction of next-generation balloon catheters with integrated imaging capabilities, such as ultrasound or fluoroscopy, to enhance procedural precision and safety
+4 more tracked in this edition
Report scope
What this report answers
The specific decisions and questions covered in the 108-page report and its accompanying data pack — tailored to this market's segments, applications, and named competitors.
- How big is the Kidney Stone Extraction Balloon Market today ($1.33 Bn base), and how fast will it grow at 7.4% CAGR through 2035?
- Which of Single Balloon, Double Balloon holds the largest share, and how do the growth rates diverge?
- How is demand distributed across Urology, Gastroenterology applications, and which application is scaling fastest?
- How do North America, Europe, Asia-Pacific, Latin America compare on market share, growth rate, and regulatory posture?
- Where do Philips Healthcare, Medtronic plc, Abbott Laboratories and 12 other named players sit in market share, tier, and product breadth?
- What are the top growth drivers (led by Rising prevalence of nephrolithiasis) and top restraints (led by High procedural costs), with quantified CAGR impact?
- What regulatory shifts and 5 tracked developments (2024–2025) materially affect the forecast?
- Which segments and geographies present the strongest investment thesis given the growth-window 2027–2031?
Market dynamics
Why the number moves this way
The forces expanding this market and the ones holding it back — each broken down into distinct, scannable points.
Growth drivers
Pulling the market up
- Rising prevalence of nephrolithiasis Global incidence of kidney stones is increasing due to dietary habits, sedentary lifestyles, and metabolic syndromes, driving demand for effective extraction solutions.
- Shift toward minimally invasive procedures Balloon-based extraction offers targeted, less invasive alternatives to traditional methods like PCNL and ESWL, reducing patient trauma and recovery times.
- Technological advancements in balloon design Innovations such as improved flexibility, durability, and imaging compatibility enhance procedural precision and safety, particularly in complex cases.
- Increased healthcare infrastructure investments Rising investments in endourology training and outpatient facilities support the adoption of advanced extraction devices.
- Regulatory support for minimally invasive devices Favorable regulatory developments favor the approval and adoption of innovative balloon-based solutions.
Restraints
Holding it back
- High procedural costs Advanced balloon extraction devices and associated technologies require significant capital investment, limiting adoption in cost-sensitive markets.
- Regulatory hurdles Approval timelines for new devices can extend by 6–12 months post-2025, delaying market entry for innovative solutions.
- Limited reimbursement policies Inconsistent reimbursement frameworks for minimally invasive procedures may restrict market growth in certain regions.
- Supply chain disruptions Component shortages, particularly for high-precision balloon materials, persisted through H1 2025, impacting production timelines.
Trends
What we're watching
- Consolidation activity is accelerating as top players seek scale advantages; the report tracks named M&A + partnerships quarterly.
- Sustainability and traceability requirements are reshaping procurement criteria across enterprise buyers.
Impact analysis
Quantified drivers & restraints
Percentages are directional contributions to overall CAGR — not additive. Full sensitivity tables in the sample.
| Driver | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising prevalence of nephrolithiasis | +3.3% | Global | 2025–2035 |
| Shift toward minimally invasive procedures | +2.1% | Global | 2025–2035 |
| Technological advancements in balloon design | +1.6% | Global | 2025–2035 |
| Increased healthcare infrastructure investments | +1.1% | Global | 2025–2035 |
Restraints impact analysis
| Restraint | % Impact on CAGR | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| High procedural costs | −1.3% | Global | 2025–2029 |
| Regulatory hurdles | −0.9% | Global | 2025–2029 |
| Limited reimbursement policies | −0.7% | Global | 2025–2029 |
The Kidney Stone Extraction Balloon Market is segmented by product type, application, end user, technology, and distribution channel.
Revenue share by type · 2025 base year
% OF $1.33 BN KIDNEY STONE EXTRACTION BALLOON MARKET · 4 TYPES COVERED
Each slice = that type's share of the total $1.33 Bn Kidney Stone Extraction Balloon Market in 2025. Shares sum to 100%. Per-segment historicals + 2035 forecasts are in the report data pack.
By type
-
Single Balloon
-
Double Balloon
By application
-
Urology
-
Gastroenterology
By end-user industry
-
Hospitals
-
Ambulatory Surgical Centers
-
Specialty Clinics
By capacity
-
value medical devices, ensuring direct engagement with healthcare providers
-
use devices, offering convenience and scalability
-
chart
-
template="vbar_3d" data
-
palette="dual_tone_teal">
-
size="15" fill="#0f172a" text
-
anchor="middle" font
-
weight="bold">Regional Coverage
Geography
Regional market share
Base-year (2025) share by region. Growth rates through 2035 vary widely by market maturity — country-level detail sits in the report.
Regional share · 2025
SHARE OF $1.33 BN BASE MARKET
Bars sized to relative regional share. Leader region highlighted in gold.
North America leads regional demand at ~40.7% in 2025. Driven by manufacturing scale and end-market density.
Competitive landscape
Who's competing, and how
The market is Low to Medium concentration. 15 named players are profiled in the report with product portfolios, financials where public, and recent strategic moves.
The Kidney Stone Extraction Balloon Market is moderately consolidated, with a mix of global and regional players. Key companies focus on product differentiation, technological innovation, and strategic partnerships to maintain market share.
Concentration snapshot
Top 5 players control ~35–50% of the market
Estimated aggregate share of the top 5 by 2025 revenue. Named breakdown + individual shares in the full report.
Competitive tiers
Players are grouped into three tiers by revenue rank, product breadth, and strategic footprint. Full tier assignment in the report.
Tier 1 · Leaders
3companies
Global scale, integrated portfolio, brand recognition. Setting the pricing benchmark.
Tier 2 · Challengers
5companies
Regional strongholds, focused portfolio, actively expanding via M&A or capacity.
Tier 3 · Emerging
7companies
Niche or early-stage, differentiated technology or early-mover positioning.
Named players covered
Every profiled company includes market rank, base-year share, revenue estimate, HQ, product portfolio depth, and recent strategic moves. Unlock in the sample.
-
Philips Healthcare
Rank 01Share est. ~16%Revenue $■■■MHQ ■■■ -
Medtronic plc
Rank 02Share ■■.■%Revenue $■■■MHQ ■■■ -
Abbott Laboratories
Rank 03Share ■■.■%Revenue $■■■MHQ ■■■ -
Johnson & Johnson MedTech
Rank 04Share ■■.■%Revenue $■■■MHQ ■■■ -
Stryker Corporation
Rank 05Share ■■.■%Revenue $■■■MHQ ■■■ -
Becton, Dickinson and Company
Rank 06Share ■■.■%Revenue $■■■MHQ ■■■ -
Boston Scientific Corporation
Rank 07Share ■■.■%Revenue $■■■MHQ ■■■ -
Siemens Healthineers
Rank 08Share ■■.■%Revenue $■■■MHQ ■■■
+ 7 more player profiles in the full report.
Unlock the full competitive landscape
Per-player market share, revenue estimates, HQ, product portfolio depth, recent M&A + partnerships, and 3-tier ranking rationale — sample included.
Regulatory landscape
Policy and standards affecting the forecast
Material regulatory shifts across the major regional markets. The report tracks these quarter-by-quarter and quantifies their forecast impact.
-
United States
FDA classifies devices by risk (Class I/II/III). 510(k) clearances (~3000/year) require substantial equivalence; PMA approvals for high-risk devices. Quality System Regulation (QSR, 21 CFR 820) transitioning to ISO 13485 alignment 2026. UDI unique device identification mandatory. FDA cybersecurity guidance for connected devices.
-
European Union
Medical Device Regulation (MDR, EU 2017/745) fully applicable 2021 — significantly stricter than replaced MDD. IVDR (in vitro diagnostics) applicable 2022. Notified Body certification bottleneck: only 40 designated bodies for entire EU. Unique Device Identification (UDI) mandatory. EUDAMED database launching in phases.
-
China / APAC
NMPA (National Medical Products Administration) approves all devices for Chinese market; typical Class III timeline 2-3 years. Volume-based procurement (VBP) reduces device prices 40-90% for included categories. Japan's PMDA aligned with FDA on many pathways. India's CDSCO expanded device oversight since 2017.
-
Global standards
ISO 13485 quality management system certification held by 30K+ device manufacturers globally. ISO 14971 risk management mandatory in most jurisdictions. IMDRF (International Medical Device Regulators Forum) coordinates harmonisation across FDA, EMA, PMDA, NMPA, Health Canada, TGA, ANVISA.
Purchase options
License this report
All licenses include the full PDF report + Excel data pack + one analyst clarification call. Choose based on how many colleagues will need access.
Single user
$3,350
- 1 named user, non-transferable
- Full PDF + Excel data pack
- 1 hour analyst clarification call
Multi user
$4,950
- Up to 5 users at one location
- Full PDF + Excel data pack
- 2 hours analyst time
- Priority email support
Corporate
$6,950
- Unlimited users org-wide
- Full PDF + Excel data pack
- 4 hours analyst time
- Presentation-ready deck
Need custom scope, region cuts, or country-level detail? Request customization or speak to an analyst.
How buying works
- 01 Select a license — your enquiry reaches the desk lead within one business day.
- 02 Invoice issued — pay by wire transfer, corporate PO, or online (PayPal / Razorpay / cards). Preferred by most procurement teams.
- 03 Report delivered — full PDF + Excel data pack + analyst call slot in your inbox on receipt of payment.
Payment methods accepted
- PayPalGlobal
- RazorpayCards · UPI · Netbanking
- Visa · Mastercard · AmexVia gateway
- Wire transferUSD · EUR · INR · GBP
- Corporate PONet-30 on approval
Invoices raised in your billing currency. Enterprise procurement docs (W-9 / W-8BEN / VAT registration) available on request.
Methodology
How we built this estimate
Every number in this report is derived from three converging paths — primary interviews, top-down macro sizing, and bottom-up named-company revenue build-up — and re-verified against live public sources at each edition refresh.
-
Primary research
Structured analyst interviews with buyers, vendors, and distributors across the value chain — top-tier OEMs, mid-market integrators, and specialised suppliers. Respondent distribution is disclosed in the sample so readers can weight the mix themselves.
-
Secondary research
Company filings, trade association reports, government statistics, and paid databases feed the top-down macro layer. Every source is footnoted in the report so any downstream reader can retrace how a number was arrived at.
-
Data triangulation
Three independent estimation paths — top-down macro sizing, bottom-up named-company build-up, and cross-check against installed-base or shipment proxies — converge to a single defensible number. Divergences greater than 8% trigger a re-review.
-
Analyst review
Every model is pressure-tested by a senior analyst before publication. Assumptions are stated explicitly, sensitivities are documented, and the accompanying Excel data pack lets clients replicate every calculation on their own inputs.
Frequently asked questions
Common questions about this report
-
How big is the Kidney Stone Extraction Balloon Market in 2025?
The Kidney Stone Extraction Balloon Market is estimated at approximately $1.33 Bn in 2025, based on triangulated bottom-up revenue and top-down macro modelling. Full annual data in the report data pack.
-
What's the forecast growth rate through 2035?
The market is projected to grow at a 7.40% CAGR from 2025 to 2035, reaching $2.72 Bn by 2035. This reflects a mix of end-user demand growth, regulatory tailwinds, and technology cost-decline. Sensitivity tables in the sample.
-
Which region leads the market?
North America leads the market, accounting for approximately 40.7% of 2025 revenue. Country-level detail is broken out in the report.
-
Which segment leads the market?
Single Balloon leads the type segmentation with an estimated 40.7% share. See the Segments section for the full breakdown across type, application, technology, and end-user.
-
Who are the major players covered?
The report profiles 15 named players including Philips Healthcare, Medtronic plc, Abbott Laboratories, Johnson & Johnson MedTech, Stryker Corporation, and others. Each profile covers product portfolio, financials where public, and recent strategic moves.
-
What's driving growth in this market?
The top growth driver is Rising prevalence of nephrolithiasis. Global incidence of kidney stones is increasing due to dietary habits, sedentary lifestyles, and metabolic syndromes, driving demand for effective extraction solutions.
-
What are the main restraints?
The primary restraint is High procedural costs. Advanced balloon extraction devices and associated technologies require significant capital investment, limiting adoption in cost-sensitive markets.
-
What are the most recent developments?
Recent notable events include: : Technological advancements: Introduction of next-generation balloon catheters with integrated imaging capabilities, such as ultrasound or fluoroscopy, to enhance procedural precision and safety; : Robotic-assisted integration: Adoption of balloon extraction devices in robotic-assisted urology surgeries, creating new opportunities for minimally invasive workflows; 2025: Regulatory approvals: Favorable regulatory developments post-2025 have accelerated the approval of innovative balloon-based solutions, supporting market growth. Full timeline in the report.
-
Can I customise the scope?
Yes. We regularly customise reports for regional cuts, country-level detail, additional segment axes, or specific company profiles. Request customization here and an analyst will scope it with you within one business day.
The Kidney Stone Extraction Balloon Market is projected to reach $2.72 Bn by 2035, up from $1.33 Bn in 2025 — a 7.40% CAGR equating to roughly 2.0× expansion. The bars anchor both endpoints so you can pressure-test the trajectory against your own assumptions.